Literature DB >> 15917199

Dyskeratosis congenita: telomerase, telomeres and anticipation.

Anna Marrone1, Amanda Walne, Inderjeet Dokal.   

Abstract

Dyskeratosis congenita (DC) is a rare bone marrow failure syndrome that displays marked clinical and genetic heterogeneity. The identification of dyskeratosis congenita gene 1 (DKC1) mutations in X-linked recessive patients initially suggested that DC is a defective pseudouridylation disorder. The subsequent identification of mutations in the telomerase RNA component (TERC) of autosomal dominant DC patients together with the discovery that both TERC and the DKC1-encoded protein, dyskerin, are closely associated in the telomerase complex have suggested that the pathophysiology of DC predominantly relates to defective telomere maintenance. Recent discoveries have shown that autosomal dominant DC exhibits disease anticipation and that this is associated with progressive telomere shortening owing to the haplo-insufficiency of TERC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917199     DOI: 10.1016/j.gde.2005.04.004

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  44 in total

1.  Structure of the Shq1-Cbf5-Nop10-Gar1 complex and implications for H/ACA RNP biogenesis and dyskeratosis congenita.

Authors:  Shuang Li; Jingqi Duan; Dandan Li; Shoucai Ma; Keqiong Ye
Journal:  EMBO J       Date:  2011-11-25       Impact factor: 11.598

Review 2.  How a single protein complex accommodates many different H/ACA RNAs.

Authors:  U Thomas Meier
Journal:  Trends Biochem Sci       Date:  2006-05-02       Impact factor: 13.807

3.  Biphasic folding kinetics of RNA pseudoknots and telomerase RNA activity.

Authors:  Song Cao; Shi-Jie Chen
Journal:  J Mol Biol       Date:  2007-01-09       Impact factor: 5.469

Review 4.  Telomere and adaptive immunity.

Authors:  Nan-ping Weng
Journal:  Mech Ageing Dev       Date:  2007-12-08       Impact factor: 5.432

5.  Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA).

Authors:  Mark Hills; Kai Lücke; Elizabeth A Chavez; Connie J Eaves; Peter M Lansdorp
Journal:  Blood       Date:  2009-04-09       Impact factor: 22.113

6.  Expression and purification of recombinant human MCT-1 oncogene in insect cells.

Authors:  Isabel Pérez-Arellano; Roberto Gozalbo-Rovira; Ana Isabel Martínez; Javier Cervera
Journal:  Protein J       Date:  2010-02       Impact factor: 2.371

7.  Architecture of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

Review 8.  Towards an understanding of regulating Cajal body activity by protein modification.

Authors:  Michael D Hebert; Aaron R Poole
Journal:  RNA Biol       Date:  2016-10-07       Impact factor: 4.652

9.  Atypical X-chromosome inactivation in an X;1 translocation patient demonstrating Xq28 functional disomy.

Authors:  Catherine E Cottrell; Annemarie Sommer; Gail D Wenger; Steven Bullard; Tamara Busch; Katherine Nash Krahn; Andrew C Lidral; Julie M Gastier-Foster
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

10.  Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly.

Authors:  Andrew S Venteicher; Zhaojing Meng; Philip J Mason; Timothy D Veenstra; Steven E Artandi
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.